tiprankstipranks
Trending News
More News >
PAUL HARTMANN AG (DE:PHH2)
:PHH2
Germany Market
Advertisement

PAUL HARTMANN AG (PHH2) Price & Analysis

Compare
1 Followers

PHH2 Stock Chart & Stats


PHH2 FAQ

What was PAUL HARTMANN AG’s price range in the past 12 months?
PAUL HARTMANN AG lowest stock price was €190.50 and its highest was €258.00 in the past 12 months.
    What is PAUL HARTMANN AG’s market cap?
    PAUL HARTMANN AG’s market cap is €863.07M.
      When is PAUL HARTMANN AG’s upcoming earnings report date?
      PAUL HARTMANN AG’s upcoming earnings report date is Mar 19, 2026 which is in 217 days.
        How were PAUL HARTMANN AG’s earnings last quarter?
        Currently, no data Available
        Is PAUL HARTMANN AG overvalued?
        According to Wall Street analysts PAUL HARTMANN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does PAUL HARTMANN AG pay dividends?
          PAUL HARTMANN AG does not currently pay dividends.
          What is PAUL HARTMANN AG’s EPS estimate?
          PAUL HARTMANN AG’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does PAUL HARTMANN AG have?
          PAUL HARTMANN AG has 3,572,424 shares outstanding.
            What happened to PAUL HARTMANN AG’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of PAUL HARTMANN AG?
            Currently, no hedge funds are holding shares in DE:PHH2

            PAUL HARTMANN AG Stock Smart Score

            6
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            31.05%
            12-Months-Change

            Fundamentals

            Return on Equity
            9.81%
            Trailing 12-Months
            Asset Growth
            7.98%
            Trailing 12-Months

            Company Description

            PAUL HARTMANN AG

            Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.

            PAUL HARTMANN AG (PHH2) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Biotest
            CompuGroup Medical
            Draegerwerk AG & Co. KGaA
            RHON-KLINIKUM AG
            Medios AG

            Ownership Overview

            <0.01%100.00%
            <0.01%
            Mutual Funds
            ― Other Institutional Investors
            100.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis